EHHADH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.66849999999808E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.42510000000507E-05 |
Normal-vs-Stage2 |
1.220030E-04 |
Normal-vs-Stage3 |
3.91659999999794E-05 |
Normal-vs-Stage4 |
9.43420000010242E-07 |
Stage1-vs-Stage2 |
9.712200E-01 |
Stage1-vs-Stage3 |
6.653000E-01 |
Stage1-vs-Stage4 |
2.278100E-02 |
Stage2-vs-Stage3 |
7.104600E-01 |
Stage2-vs-Stage4 |
1.245370E-01 |
Stage3-vs-Stage4 |
1.958210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.08560000000335E-05 |
Normal-vs-AfricanAmerican |
4.49479999997671E-06 |
Normal-vs-Asian |
9.259500E-02 |
Caucasian-vs-AfricanAmerican |
1.100820E-01 |
Caucasian-vs-Asian |
6.006000E-01 |
AfricanAmerican-vs-Asian |
4.779800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.9923999999969E-05 |
Normal-vs-Female |
2.28689999999254E-05 |
Male-vs-Female |
5.531000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.2827000000003E-05 |
Normal-vs-Extreme_Weight |
3.65229999998995E-06 |
Normal-vs-Obese |
6.28819999999308E-05 |
Normal-vs-Extreme_Obese |
7.729700E-02 |
Normal_Weight-vs-Extreme_Weight |
6.056200E-01 |
Normal_Weight-vs-Obese |
6.010600E-01 |
Normal_Weight-vs-Extreme_Obese |
1.145430E-01 |
Extreme_Weight-vs-Obese |
2.208400E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.443350E-01 |
Obese-vs-Extreme_Obese |
2.231200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.84970000000262E-06 |
Normal-vs-Age(41-60Yrs) |
5.96360000000296E-05 |
Normal-vs-Age(61-80Yrs) |
2.06249999999963E-05 |
Normal-vs-Age(81-100Yrs) |
6.316800E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.195220E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.402400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.268400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.865800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.506800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.158000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.85763999999145E-05 |
Normal-VS-Type2 PRCC |
5.230800E-04 |
Normal-VS-KIRP CIMP |
4.52589999921926E-08 |
Normal-VS-Unclassified PRCC |
5.61729999999372E-05 |
Type1 PRCC-VS-Type2 PRCC |
6.596100E-03 |
Type1 PRCC-VS-KIRP CIMP |
6.11529999999805E-05 |
Type1 PRCC-VS-Unclassified PRCC |
5.353600E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.20239999956695E-07 |
Type2 PRCC-VS-Unclassified PRCC |
5.322300E-02 |
KIRP CIMP-VS-Unclassified PRCC |
5.93089999999519E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.041510E-04 |
Normal-vs-N1 |
3.37790000004556E-06 |
Normal-vs-N2 |
1.53586999999122E-05 |
N0-vs-N1 |
1.458590E-01 |
N0-vs-N2 |
1.825000E-01 |
N1-vs-N2 |
1.748950E-01 |
|
|